tiprankstipranks
Trending News
More News >
BioRegenx (BRGX)
OTHER OTC:BRGX
US Market

BioRegenx (BRGX) Income Statement

Compare
23 Followers

BioRegenx Income Statement

Last quarter (Q3 2025), BioRegenx's total revenue was $507.75K, a decrease of -14.81% from the same quarter last year. In Q3, BioRegenx's net income was $-80.56K. See BioRegenx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.34M$ 22.24K$ 42.16K$ 198.58K$ 404.39K
Gross Profit
$ 1.66M$ 16.31K$ 36.23K$ 198.03K$ 359.36K
Operating Expenses
$ 23.74M$ 125.97K$ 114.53K$ 363.15K$ 575.01K
Depreciation and Amortization
$ 0.00$ 5.93K$ 5.93K$ 4.45K$ 5.93K
EBITDA
$ -22.76M$ -557.07K$ -72.38K$ -161.00K$ -152.00K
Operating Income
$ -22.76M$ -110.00K$ -78.31K$ -165.00K$ -216.00K
Other Income/Expenses
$ -290.66K$ -462.00K$ 0.00$ 68.25K$ -58.09K
Pretax Income
$ -23.05M$ -571.00K$ -78.31K$ -96.87K$ -274.00K
Net Income
$ -23.05M$ -571.00K$ -78.31K$ -96.87K$ -332.00K
Per Share Metrics
Basic EPS
$ -0.02$ >-0.01$ >-0.01$ >-0.01$ >-0.01
Diluted EPS
$ -0.02$ >-0.01$ >-0.01$ >-0.01$ >-0.01
Weighted Average Shares Outstanding
939.51M 276.37M 269.75M 269.75M 267.96M
Weighted Average Shares Outstanding (Diluted)
939.51M 276.37M 269.75M 269.75M 267.96M
Currency in USD

BioRegenx Earnings and Revenue History